Stilbenes
Tamoxifen Citrate Bundled By Tamoxifen USA Generates High Interest
Published in Women's Health Weekly, April 21st, 2011
Tamoxifen USA publicized today another breakthrough for the research chemical sector. Tamoxifen is an antagonist of the oestrogen receptor in breast tissue as a result of its active metabolite, hydroxytamoxifen. In different tissues such as the endometrium, it behaves as an agonist, hence tamoxifen may be portrayed as a combined agonist/antagonist. It has been the conventional hormonal (anti-estrogen) therapy for hormone receptor-positive early breast cancer in pre-menopausal women, although aromatase inhibitors have been recommended.
Tamoxifen...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Endometriosis
Data from Cornell University Provide New Insights into Endometriosis - Ovarian Cancer
Data from K.D. Swenerton and Colleagues Advance Knowledge in Ovarian Cancer - Breast Cancer
Data from M. Weichhaus and Colleagues Advance Knowledge in Breast Cancer - Menopause
Data from Y.S. Yang and Colleagues Advance Knowledge in Menopause - Cervical Cancer
Data on Cervical Cancer Published by Researchers at University of Kentucky - Menopause
Data on Menopause Described by Researchers at University of Copenhagen - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
